"Hefei Major Emerging Industry Construction Program of Precision Medicine”undertaken by HTBT was selected as the first batch of major emerging industry construction projects in Anhui province.

The "aspart insulin R&D" project was listed as a Scientific Breakthrough Program project of Anhui Province 2016 by the Science and Technology Department of Anhui Province.

"New insulin analogue R&D" project was listed as a Foreign Intelligence Introduction Program project as well as a provincial key project 2013, a national key project 2014, a national key project 2015 and a national key project 2016 by the State Administration of Foreign Experts Affairs and the Bureau of Foreign Experts Affairs of Anhui Province.

The project of "eco-friendly key production technology platform of recombinant human insulin and insulin analogues and pre-clinical research of novel long-acting insulin analogues (VAN-103) was listed as a major new drug discovery technology project by the Management Office of Major New Drug Discovery Technology Projects.

The "joint R&D project of insulin glargine analogues" was listed as an international cooperation project of Anhui Province 2014 by the Science and Technology Department of Anhui Province.

The "joint R&D project of new insulin analogues" was listed as an international science and technology cooperation project by the Department of International Cooperation, the Ministry of Science and Technology.

The “recombinant human insulin and insulin analogue process development and industrialization” project was listed as one of the first group of independent innovation fund projects by the Science and Technology Department of Anhui Province.

The "recombinant human insulin laboratory" project was listed as an international cooperation project of Anhui province 2010 by the Science and Technology Department of Anhui Province.